650 nmVisible red light3 minPer session0.29 mWThrough a 4 mm pupil
650 nmVisible red light
3 minPer session
0.29 mWThrough a 4 mm pupil
3–16Years of age
A complete solution
01
The device
Compact and portable, with a child-friendly touchscreen guide and automatic session logging.
Session logPatient A-102
MonTueWedThuFri
Compliance90%
02
Online monitoring
Clinicians see compliance, session data and safety reports for each patient, from anywhere.
03
Support
Training for clinic teams, onboarding for families and local technical support from IHCC.
The Eyerising Myopia Management Device
Key specifications
01Therapy
Repeated low-level red light (RLRL)
02Wavelength
650 nm visible red light
03Output
0.29 mW through a 4 mm pupil
04Session
3 minutes
05Schedule
2 sessions a day, at least 4 hours apart, 5 days a week
06Age range
3 to 16 years
07Use
At home, under clinical supervision
08Controls
Touchscreen with guided sessions
09Connectivity
Wi-Fi or 4G, sessions synced to the online system
Designed for children
01On the desk at home02A session in progress03Monitored by parents04The guided start screen
Safety and supervision
Treatment starts only after a full eye examination and a prescription.
Regular follow-ups check visual acuity, axial length and retinal health.
A minimum of 4 hours between sessions is built into the device.
Stop treatment and contact the eye-care professional if there is any discomfort or change in vision.
Regulatory status
Registered in more than 40 markets, including Saudi Arabia, the UAE, the EU, the UK and Australia, and manufactured under an ISO 13485:2016 quality system.
SFDA MDMA-2-2025-3726Saudi Arabia
ARTG 412752Australia
ISO 13485:2016Certified manufacturing
40+ countriesRegulatory approvals
Results vary between children. Treatment must be prescribed and monitored by an eye-care professional.
Offer RLRL therapy at your clinic
Talk to IHCC about partnership, training and a demo device.